Charles River Laboratories (NYSE: CRL)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Charles River Laboratories Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Charles River Laboratories Company Info
Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies.
News & Analysis
It's older than the dinosaurs.
Just the facts, Fool.
Checking expectations
Don't just ask, "How much inventory?" Ask, "What kind?"
Just the facts, Fool.
Checking expectations
Just the facts, Fool.
Checking expectations
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Earnings Transcripts
CRL earnings call for the period ending September 30, 2021.
CRL earnings call for the period ending June 30, 2021.
CRL earnings call for the period ending March 31, 2021.
CRL earnings call for the period ending February 17, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.